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A B S T R A C T   
The stereospecific structure of triacylglycerols (TAGs) affects the bioavailability of fatty acids. Lack of en-
antiopure reference compounds and effective enantiospecific methods have hindered the stereospecific analysis 
of individual TAGs. Twelve novel enantiostructured AAB-type TAGs were synthesized containing one of the 
three n-3 polyunsaturated fatty acid: α-linolenic acid (ALA), eicosapentaenoic acid (EPA), or docosahexaenoic 
acid (DHA) in sn-1 or sn-3 position. These compounds formed six enantiomer pairs, which were separated with 
recycling high-performance liquid chromatography using chiral columns and UV detection. The chromato-
graphic retention behavior of the enantiomers and the stereospecific elution order were studied. The enantiomer 
with an n-3 PUFA in the sn-1 position eluted faster than the enantiomer with the n-3 PUFA in the sn-3 position, 
regardless of the carbon chain length and number of double bonds of the PUFA. TAG enantiomers containing 
DHA exhibited highly different retention on the chiral column and were separated after the first column, 
whereas recycling was needed to separate the enantiomer pairs containing ALA or EPA. The system using two 
identical columns and one mobile phase, without sample derivatization, proved to be very effective also for peak 
purity assessment, confirming the enantiopurity of the synthesized structured TAGs being higher than 98 % (96 
% ee).   
1. Introduction 
There is an increasing interest in the health effects of n-3 poly-
unsaturated fatty acids (PUFAs). α-Linolenic acid (18:3n-3, ALA) is an 
essential fatty acid and a precursor for synthesis of other long-chain n-3 
PUFAs. Due to the low conversion of ALA to eicosapentaenoic acid 
(20:5n-3, EPA) and docosahexaenoic acid (22:6n-3, DHA), also EPA and 
DHA are often considered as essential components in the diet (Swanson 
et al., 2012). In addition to fatty acid composition, the positional dis-
tribution of the fatty acids in triacylglycerols (TAGs) is an important 
quality parameter as it affects the bioavailability of fatty acids. 
In TAGs, the fatty acyl groups are covalently attached by ester bonds 
in the glycerol backbone in one of the three stereospecifically distinct 
locations termed sn-1, sn-2 and sn-3 (IUPAC-IUB Commission on 
Biochemical Nomenclature, 1977). When the two terminal primary 
hydroxyl groups of a glycerol are esterified with different fatty acids, 
the resulting TAG displays chiral asymmetry and thus, has two en-
antiomers. While enantiomers may differ only slightly in their chemical 
and physical properties, they are likely to have different biological 
activities in chiral environments like in the human body due to the 
three-dimensional structure-activity relationships (Smith, 2009). The 
stereospecific distribution of fatty acids in TAGs of natural fats and oils 
is under genetic control, making the positional distribution of fatty 
acids not random (Brockerhoff, 1971; Vichi et al., 2007). 
Chirality of the other major food components like proteins and 
carbohydrates is well studied (Marchelli et al., 1996; Zawirska- 
Wojtasiak, 2006), whereas knowledge of the enantiomeric composition 
of lipids, TAGs in particular, is limited. To understand the health impact 
of nutritionally important fatty acids in natural TAG molecules in foods, 
reliable methods and tools are needed to study their enantiospecific 
location within the TAGs. Synthesis of novel enantiopure reference 
compounds is crucial for research on structure-activity relationship of 
TAGs and for development of analytical methods of TAG enantiomers 
(Kalpio et al., 2015; Kristinsson et al., 2014). Enantioselective HPLC is a 
promising technique with (Kalpio et al., 2015; Nagai et al., 2011) and 
without sample recycling systems (Lísa and Holčapek, 2013; Řezanka 
et al., 2018) to investigate the stereospecific distribution of fatty acids 
in TAGs of natural sources. Further research related to stereospecific 
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separation of TAGs is still needed, to improve the separation of re-
gioisomers and enantiomers in a single analysis. 
In order to enable the bioavailability studies of n-3 PUFAs located in 
different sn-positions, various types of structured TAGs possessing EPA and 
DHA have been synthesized. These TAGs include normal-structured MLM 
(medium-long-medium) and similar ABA type TAGs possessing pure EPA 
or DHA located in the sn-2 position along with saturated even carbon 
number fatty acids ranging from C2 to C18 occupying the sn-1,3-terminal 
positions of the TAGs (Halldorsson et al., 2003; Haraldsson et al., 2000;  
Magnusson and Haraldsson, 2010). Furthermore, reversed-structured 
TAGs of the LML type have also been synthesized, possessing saturated 
fatty acids (SAFAs) in the sn-2 position and EPA or DHA located in the sn- 
1,3 positions (Gudmundsdottir et al., 2015; Magnusson and Haraldsson, 
2012). These syntheses were all based on the use of a highly regioselective 
Candida antarctica lipase (CAL) immobilized as CAL-B, which played a key 
role in the syntheses by offering a full regiocontrol in terms of directing the 
SAFAs activated as vinyl esters exclusively into the less hindered terminal 
positions of glycerol. The same lipase offered similar regiocontrol in di-
recting the n-3 PUFAs, activated as oxime esters, into the terminal posi-
tions of the glycerol backbone (Magnusson and Haraldsson, 2012). The use 
of activated fatty acids was essential for ensuring fast action of the lipase 
under mild temperature to avoid acyl migration side reaction (Compton 
et al., 2012; Laszlo et al., 2008), which is critical for the regiocontrol of the 
reactions. 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride 
(EDCI) was subsequently used as a coupling agent to chemically in-
corporate the n-3 PUFAs or SAFAs into the mid-position of the resulting 
1,3-DAGs in highly efficient two-step chemoenzymatic processes. 
In this study, our aim was to synthesize and chromatographically 
separate the enantiostructured AAB type TAGs containing one n-3 
PUFA (ALA, EPA, or DHA) in sn-1 or sn-3 position. There are various 
reasons for the interest in enantiostructured TAGs possessing n-3 PUFA 
esterified to enantiospecific positions of the glycerol molecule. One was 
to design enantiostructured AAB type TAGs possessing pure ALA, EPA, 
or DHA in the sn-1, sn-2 or sn-3 position as unique TAG model mole-
cules for investigating the impact of enantiospecific position of EPA and 
DHA on the bioavailability of these n-3 PUFAs in animals and humans 
(Linderborg et al., 2019). Symmetric TAGs constituting EPA and DHA 
in their sn-2 position are already available and fully characterized 
through the aforementioned synthesis, whereas the synthesis of the 
corresponding asymmetric TAGs has not been reported before. Sec-
ondly, we aim to extend our previous research on synthesis and en-
antiospecific separation of enantiostructured AAB type TAGs (Kalpio 
et al., 2015). In that study, the enantiomeric separation was performed 
on two AAB types of enantiostructured TAGs containing C12–C22 fatty 
acids with 0–2 double bonds (DBs), namely TAGs possessing two 
identical saturated fatty acids along with one unsaturated fatty acid, as 
well as TAGs possessing two identical unsaturated fatty acyl groups and 
one saturated one. In the current paper, we address a new challenge in 
the synthesis and analysis of enantiostructured AAB type TAGs pos-
sessing n-3 PUFAs with 3–6 DBs (ALA, EPA, or DHA) in one of the 
enantiomeric sn-1/sn-3 positions along with pure stearic (C18:0) or 
palmitic acids (C16:0) in the remaining positions. Separation of the 
resulting TAG enantiomers by the chiral-phase HPLC will produce novel 
information on elution order of TAG enantiomers containing n-3 
PUFAs. Further, this will provide unique data for investigating the in-
fluence of carbon chain length and the number of DBs on the elution 
order of TAG enantiomers. 
2. Materials and methods 
2.1. Materials and methods of synthesis 
2.1.1. General 
1H and 13C nuclear magnetic resonance spectra were recorded on a 
Bruker Avance 400 spectrometer at 400 and 101 MHz, respectively, and 
referenced to the residual peak stated (CDCl3, δ = 7.26/77.2). 
Chemical shifts (δ) are reported in parts per million (ppm) and the 
coupling constants (J) are reported to the nearest 0.5 Hz. The following 
abbreviations are used to describe the multiplicity: s, singlet; d, doublet; 
t, triplet; q, quartet; quin, quintet; dd, doublet of doublets; m, multiplet. 
Infrared spectra were conducted on a Thermo Nicolet FT-IR iS10 
Spectrophotometer on a KBr pellet (crystalline material) or as a neat 
liquid (oils). Melting points were determined on a Büchi 520 melting 
point apparatus and are uncorrected. The high-resolution mass spectra 
(HRMS) were acquired on a Bruker micrOTOF-Q mass spectrometer. All 
data analysis was done on Bruker software. Optical activity measure-
ments were performed on an AutopolR V Automatic Polarimeter from 
Rudolph Research Analytical using a 40T-2.5-100-0.7 Temp Trol™ po-
larimetric cell with 2.5 mm inside diameter, 100 mm optical path 
length and 0.7 mL volume with c referring to g sample/100 mL. 
The immobilised Candida antarctica lipase (Novozym 435; CAL-B) 
was supplied as a gift from Novozymes A/S (Bagsvaerd, Denmark). All 
chemicals and solvents were used without further purification unless 
otherwise stated. (R)-(-)-2,2-Dimethyl-1,3-dioxolane-4-methanol (R- 
solketal, 98 % purity and 99 % ee) and (S)-(+)-2,2-Dimethyl-1,3-di-
oxolane-4-methanol (S-solketal, 98 % purity and 99 % ee) were pur-
chased from Sigma-Aldrich (Steinheim, Germany). EDCI (1-(3-di-
methylaminopropyl)-3-ethylcarbodiimide hydrochloride, 98 %) was 
obtained commercial grade from Sigma-Aldrich (Steinheim, Germany) 
and 4-dimethylaminopyridine (DMAP, 99 %) from Acros Organics 
(Geel, Belgium). Benzyl bromide (98 %), sodium hydride (60 % dis-
persion in mineral oil) and 10 % palladium on carbon catalyst were 
from Sigma-Aldrich (Steinheim). ALA, EPA, DHA, palmitic acid and 
stearic acid were all obtained as free acids in high (>99 %) purity from 
Larodan Fine Chemicals (Malmö, Sweden). For the larger scale material 
intended for the animal studies, DHA (≥ 95 %) was obtained as ethyl 
ester from Pronova BioPharma (Sandefjord, Norway) and hydrolysed to 
the corresponding free acid (Haraldsson et al., 2000). Dichloromethane 
and ethyl acetate were obtained as HPLC grade from Sigma-Aldrich 
(Steinheim, Germany), n-hexane as p.a. from Merck (Darmstadt, Ger-
many), petroleum ether, boiling range 40−60 °C, and ethanol (99.8 %) 
from Honeywell (Seelze, Germany). Dichloromethane was dried over 
CaH2 under dry nitrogen atmosphere. Tetrahydrofuran for analysis was 
obtained from Acros Organics (Geel, Belgium) and dried over Na wire 
in presence of benzophenone under dry nitrogen atmosphere. Column 
chromatography was performed on Silica gel 60 (Silicycle, Ontario, 
Canada). Reactions were monitered by TLC on Silica gel 60 F254 (Si-
licycle, Ontario, Canada), with detection by quenching of fluorescence 
and/or with phosphomolybdic acid in ethanol. 
2.1.2. Syntheses 
2.1.2.1. 3-O-Benzyl-sn-glycerol, (R)-1. Sodium hydride (13.4 g, 60 wt % 
dispersion in mineral oil, 336 mmol, 3.0 equiv.) was treated several 
times with dry pet. ether using a syringe to remove the mineral oil. To 
the resulting suspension in THF (280 mL) at 0 °C was added (S)-solketal 
(14.0 mL, 112 mmol, 1.0 equiv.) dropwise via syringe. The cooling bath 
was removed, and the resulting suspension was stirred at room 
temperature for 1 h before being cooled back to 0 °C followed by 
dropwise addition of benzyl bromide (15.9 mL, 134 mmol, 1.2 equiv.). 
The resulting mixture was brought to reflux and stirred for 4 h after 
which it was cooled to 0 °C, diluted carefully with EtOH (172 mL), 
followed by addition of a 2.0 M aqueous solution of HCl (168 mL). After 
stirring at 80 °C for 1 h, the resulting mixture was cooled to room 
temperature and quenched by addition of a saturated aqueous solution 
of NaHCO3 (300 mL). The organic layer was separated and the aqueous 
layer further extracted with EtOAc (3 × 200 mL), the combined organic 
layers were dried over anhydrous Na2SO4, filtered and concentrated in 
vacuo to give the crude product which was purified via column 
chromatography (petroleum ether / EtOAc (50 %) → petroleum ether 
/ EtOAc (80 %)) to give (R)-1 (19.8 g, 109 mmol, 97 %) as a yellow oil; 
[α]D24 +5.10 (c 19.6, CHCl3); Rf 0.20 (petroleum ether / EtOAc (70 
%)); 1H NMR (400 MHz, CDCl3) δH 7.40−7.27 (5H, m, ArH), 4.56 (2H, 
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s, OCH2Ar), 3.95−3.85 (1H, m, CHOH), 3.77−3.69 (1H, m, CH2OH), 
3.67−3.62 (1H, m, CH2’OH), 3.59 (1H, dd, J = 9.5 and 4.0 Hz, 
CH2OBn), 3.55 (1H, dd, J = 9.5 and 6.0 Hz, CH2’OBn), 2.57 (1H, d, J = 
4.5 Hz, OH), 2.06 (1H, app. t, J =6.0 Hz, OH); 13C NMR (101 MHz, 
CDCl3) δC 137.7, 128.5(2), 127.9, 127.8(2), 73.6, 71.8, 70.6, 64.1. 
Spectroscopic data was in agreement with that obtained for (S)-1 as 
previously reported (Kristinsson et al., 2014). 
2.1.2.2. 1-O-Benzyl-sn-glycerol, (S)-1. (S)-1 was prepared in accordance 
with (R)-1. Spectroscopic data was identical to (R)-1 and in agreement 
with that as previously reported (Kristinsson et al., 2014). For more 
details, please see Supplementary material. 
2.1.2.3. General procedure a: enzymatic di-acylation procedure. A 
mixture of benzyl-protected glycerol (1.0 equiv.) and saturated fatty 
acid (2.1 equiv.) were brought to a melt (80 °C) followed by addition of 
an immobilized Candida antarctica lipase B (CAL-B) (5.0–10.0 wt % of 
total mass). Next, vacuum was carefully applied and the resulting 
suspension stirred at 80 °C at a rate not damaging the lipase carrier 
material for 16−48 h before being cooled to room temperature. The 
resulting solid material was dissolved in CH2Cl2, the lipase separated by 
filtration and the filtrate concentrated in vacuo to give the crude 
product which was purified by recrystallization. 
2.1.2.4. 3-O-Benzyl-1,2-dihexadecanoyl-sn-glycerol, (S)-2a. (S)-2a was 
prepared using General Procedure A, with (R)-1 (3.15 g, 17.3 mmol), 
palmitic acid (9.1 g, 35.5 mmol) and CAL-B (1.20 g, 10.0 wt%) with a 
reaction time of 16 h. Purification by recrystallization from hot ethanol 
gave (S)-2a (9.87 g, 15.0 mmol, 87 %) as colourless crystals; M.p. 
42.5–43.4 °C; [α]D25 +6.52 (c 2.3, CHCl3); Rf 0.30 (petroleum ether / 
EtOAc (10 %)); IR (thin film, νmax / cm−1) 2917, 2849, 1731; 1H NMR 
(400 MHz, CDCl3) δH 7.38−7.27 (5H, m, PhH), 5.28−5.19 (1H, m, 
CHOCO), 4.52 (1H, d, J =12.0 Hz, OCH2Ph), 4.51 (1H, d, J =12.0 Hz, 
OCH2’Ph), 4.34 (1H, dd, J = 12.0 and 4.0 Hz, CH2OCO), 4.19 (1H, dd, J 
= 12.0 and 6.5 Hz, CH2’OCO), 3.60 (1H, dd, J = 11.5 and 5.0 Hz, 
CH2OBn), 3.57 (1H, dd, J = 11.5 and 5.0 Hz, CH2’OBn), 2.32 (2H, t, J 
=7.5 Hz, CH2COO), 2.27 (2H, t, J =7.5 Hz, CH2COO), 1.67−1.51 (4H, 
m, 2 × CH2CH2COO), 1.37−1.18 (48H, m, 24 × CH2), 0.88 (6H, t, J 
=6.5 Hz, 2 × CH3); 13C NMR (101 MHz, CDCl3) δC 173.4, 173.2, 
137.7, 128.4(2), 127.8, 127.6(2), 73.3, 70.0, 68.3, 62.7, 34.3, 34.1, 
31.9, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 25.0, 24.9, 22.7, 
14.1; HRMS (ESI+) calc. for C42H74O5Na [M + Na]+ 681.5428, found 
681.5410. 
2.1.2.5. 1-O-Benzyl-2,3-dihexadecanoyl-sn-glycerol, (R)-2a. (R)-2a was 
prepared using General Procedure A, and the spectroscopic data was 
identical to that obtained for (S)-2a. For further details, please see 
Supplementary material. 
2.1.2.6. 3-O-Benzyl-1,2-dioctadecanoyl-sn-glycerol, (S)-2b. (S)-2b was 
prepared using General Procedure A, with (R)-1 (12.1 g, 66.6 mmol), 
stearic acid (40.0 g, 141 mmol) and CAL-B (2.60 g, 5.0 wt %) with a 
reaction time of 48 h. Purification by recrystallization from hot ethanol 
gave (S)-2b (46.0 g, 64.3 mmol, 97 %) as colourless crystals; M.p. 
49.7–50.4 °C; [α]D27 +6.08 (c 20.3, CHCl3); Rf 0.87 (petroleum ether / 
EtOAc (40 %)); IR (thin film, νmax / cm−1) 2917, 2847, 1747, 1730; 1H 
NMR (400 MHz, CDCl3) δH 7.38−7.26 (5H, m, PhH), 5.28−5.18 (1H, 
m, CHOCO), 4.52 (1H, d, J =12.0 Hz, OCH2Ph), 4.51 (1H, d, J =12.0 
Hz, OCH2’Ph), 4.35 (1H, dd, J = 12.0 and 4.0 Hz, CH2OCO), 4.19 (1H, 
dd, J = 12.0 and 6.5 Hz, CH2’OCO), 3.60 (1H, dd, J = 11.5 and 5.0 Hz, 
CH2OBn), 3.57 (1H, dd, J = 11.5 and 5.0 Hz, CH2’OBn), 2.32 (2H, t, J 
=7.5 Hz, CH2COO), 2.28 (2H, t, J =7.5 Hz, CH2COO), 1.68−1.55 (4H, 
m, 2 × CH2CH2COO), 1.38−1.18 (56H, m, 28 × CH2), 0.88 (6H, t, J 
=6.5 Hz, 2 × CH3); 13C NMR (101 MHz, CDCl3) δC 173.6, 173.3, 
137.9, 128.6(2), 127.9, 127.8(2), 73.5, 70.2, 68.4, 62.8, 34.5, 34.3, 
32.1, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 25.1, 25.0, 
22.9, 14.3; HRMS (ESI+) calc. for C46H82O5Na [M + Na]+ 737.6054, 
found 737.6051. 
Spectroscopic data was in agreement with that as previously re-
ported (Kristinsson et al., 2014). 
2.1.2.7. 1-O-Benzyl-2,3-dioctadecanoyl-sn-glycerol, (R)-2b. (R)-2b was 
prepared using General Procedure A, and spectroscopic data was 
identical to that obtained for (S)-2b. For more details, please see 
Supplementary material. 
2.1.2.8. General procedure B: catalytic hydrogenolysis procedure. An 
oven-dried round-bottom flask, equipped with a stirrer bar, was 
charged with benzyl-protected glycerol (1.0 equiv.) and Pd/C (10 wt 
% Pd, 3−5 mol%). The flask was evacuated, filled with nitrogen, the 
appropriate volume of hexane (10.0 mL / mmol substrate) and THF (1.0 
mL / mmol substrate) added, and the flask was purged with hydrogen 
before a single drop of HClO3 (70 wt% in water) was added. 
Hydrogenation (H2 balloon) was conducted at r.t. with vigorous 
stirring until completion (monitored by TLC). The reaction mixture 
was then diluted with THF, filtered through Celite and concentrated in 
vacuo to give the crude product which was purified by recrystallization. 
2.1.2.9. 1,2-Dihexadecanoyl-sn-glycerol, (S)-3a. (S)-3a was prepared 
using General Procedure B, with (S)-2a (9.85 g, 14.9 mmol), Pd/C 
(792 mg, 10 wt% Pd, 0.75 mmol. 5.0 mol %) and HClO3 (single drop, 
70 wt % in water) in hexane (150 mL) and THF (15 mL), with a reaction 
time of 4 h. Purification by recrystallization from hot hexane gave (S)- 
3a (8.24 g, 14.5 mmol, 97 %) as colourless crystals; 
1H NMR (400 MHz, CDCl3) δH 5.08 (1H, app. quin, J =5.0 Hz, 
CHOCO), 4.32 (1H, dd, J = 12.0 and 4.5 Hz, CH2OCO), 4.24 (1H, dd, J 
= 12.0 and 5.5 Hz, CH2’OCO), 3.76−3.70 (2H, m, CH2OH), 2.27 (4H, 
app. q, J =7.5 Hz, 2 × CH2COO), 2.01 (1H, t, J =6.5 Hz, OH), 
1.68−1.57 (4H, m, 2 × CH2CH2COO), 1.37−1.19 (48H, m, 24 × 
CH2), 0.88 (6H, t, J =6.5 Hz, 2 × CH3); 13C NMR (101 MHz, CDCl3) δC 
173.8, 173.4, 72.1, 62.0, 61.6, 34.3, 34.1, 31.9, 29.8, 29.7, 29.6, 29.5, 
29.4, 29.3, 29.2, 29.1, 29.0, 25.0, 24.9, 22.7, 14.1 
Spectroscopic data was in agreement with that as previously re-
ported (Kristinsson et al., 2014). 
2.1.2.10. 2,3-Dihexadecanoyl-sn-glycerol, (R)-3a. (R)-3a was prepared 
using General Procedure B. Spectroscopic data was identical to (S)-3b 
and in agreement with that as previously reported (Kristinsson et al., 
2014). For further details, please see Supplementary material. 
2.1.2.11. 1,2-Dioctadecanoyl-sn-glycerol, (S)-3b. (S)-3b was prepared 
using General Procedure B, with (S)-2b (2.05 g, 2.80 mmol), Pd/C 
(100 mg, 10 wt % Pd, 94.0 μmol. 3.5 mol %) and HClO3 (single drop, 70 
wt % in water) in hexane (30 mL) and THF (3.0 mL), with a reaction 
time of 15 min. Purification by recrystallization from hot hexane gave 
(S)-3b (1.53 g, 2.45 mmol, 88 %) as colourless crystals; 
1H NMR (400 MHz, CDCl3) δH 5.15−5.00 (1H, m, CHOCO), 4.32 
(1H, dd, J = 12.0 and 4.5 Hz, CH2OCO), 4.23 (1H, dd, J = 12.0 and 5.5 
Hz, CH2’OCO), 3.81−3.63 (2H, m, CH2OH), 2.34 (2H, t, J =7.5 Hz, 
CH2COO), 2.32 (2H, t, J =7.5 Hz, CH2COO), 2.03 (1H, t, J =6.5 Hz, 
OH), 1.68−1.58 (4H, m, 2 × CH2CH2COO), 1.38−1.18 (56H, m, 28 × 
CH2), 0.88 (6H, t, J =6.5 Hz, 2 × CH3); 13C NMR (101 MHz, CDCl3) δC 
173.9, 173.6, 72.3, 62.2, 61.7, 34.5, 34.3, 32.1, 29.9, 29.8, 29.7, 29.6, 
29.5, 29.4, 29.3, 29.2, 25.1, 25.0, 22.9, 14.3. 
Spectroscopic data was in agreement with that as previously re-
ported (Kristinsson et al., 2014). 
2.1.2.12. 2,3-Dioctadecanoyl-sn-glycerol, (R)-3b. (R)-3b was prepared 
using General Procedure B, and the spectroscopic data was identical to 
(S)-3b and in agreement with that as previously reported (Kristinsson 
et al., 2014). For further details, please see Supplementary material. 
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2.1.2.13. General procedure C: Steglich esterification procedure. To a 
solution of diacylglycerol (1.0 equiv), N-(3-dimethylaminopropyl)-N’- 
ethylcarbodiimide hydrochloride (EDCI) (1.1–1.2 equiv.) and 4- 
(dimethylamino)pyridine (DMAP) (0.2−0.4 equiv.) in CH2Cl2 (2.5 
mL / mmol substrate), was added the corresponding unsaturated fatty 
acid (1.05–1.2 equiv.). After stirring overnight at room temperature, 
the resulting crude mixture was directly purified via column 
chromatography. 
2.1.2.14. 1,2-Dihexadecanoyl-3-(9Z,12Z,15Z)-octadeca-9,12,15- 
trienoyl)-sn-glycerol, (R)-4a. (R)-4a was prepared using General 
Procedure C, with (S)-3a (195 mg, 0.34 mmol), ALA (109 μL, 0.36 
mmol, 1.05 equiv.), EDCI (80.0 mg, 0.42 mmol, 1.2 equiv.) and DMAP 
(9.0 mg, 0.07 mmol, 0.2 equiv.) in CH2Cl2 (0.85 mL). Purification via 
column chromatography (petroleum ether / EtOAc (5 %) gave (R)-4a 
(273 mg, 0.33 mmol, 97 %) as a white waxy solid (with a tint of 
yellow); 
[α]D25 +0.02 (c 16.3, CHCl3); Rf 0.74 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3012, 2917, 2849, 1732; 1H NMR (400 
MHz, CDCl3) δH 5.50−5.25 (7H, m, 6 × =CH and CHOCO), 4.29 (2H, 
dd, J = 12.0 and 4.0 Hz, 2 × CH2OCO), 4.14 (2H, dd, J = 12.0 and 6.0 
Hz, 2 × CH2’OCO), 2.81 (4H, app. t, J =6.5 Hz, 2 × =CCH2C=), 
2.37−2.26 (6H, m, 3 × CH2COO), 2.14−2.01 (4H, m, =CCH2CH3 and 
= CCH2CH2), 1.67−1.55 (6H, m, 3 × CH2CH2COO), 1.39−1.18 (56H, 
m, 28 × CH2), 0.98 (3H, t, J =7.5 Hz, =CCH2CH3), 0.88 (6H, t, J =6.5 
Hz, 2 × CH3); 13C NMR (101 MHz, CDCl3) δC 173.4, 173.3, 173.0, 
132.1, 130.4, 128.4, 128.3, 127.9, 127.3, 69.0, 62.3 (2), 34.4, 34.3, 
34.2, 32.1, 30.1, 30.0, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 
29.1, 29.0, 27.4, 25.8, 25.7, 25.1, 25.0, 24.9, 22.8, 20.7, 14.4, 14.3; 
HRMS (ESI+) calc. for C53H96O6Na [M + Na]+ 851.7099, found 
851.7094. 
2.1.2.15. 2,3-Dihexadecanoyl-1-(9Z,12Z,15Z)-octadeca-9,12,15- 
trienoyl)-sn-glycerol, (S)-4a. (S)-4a was prepared using General 
Procedure C, and the spectroscopic data was identical to that 
obtained for (R)-4a. For further details, please see Supplementary 
material. 
2.1.2.16. 1,2-Dioctadecanoyl-3-(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl)- 
sn-glycerol, (R)-4b. (R)-4b was prepared using General Procedure C, 
with (S)-3b (302 mg, 0.48 mmol), ALA (168 μL, 0.56 mmol, 1.15 
equiv.), EDCI (114 mg, 0.60 mmol, 1.2 equiv.) and DMAP (14.0 mg, 
0.12 mmol, 0.2 equiv.) in CH2Cl2 (1.2 mL). Purification via column 
chromatography (petroleum ether / EtOAc (5 %) gave (R)-4b (411 mg, 
0.46 mmol, 96 %) as a white waxy solid (with a tint of yellow); 
[α]D25 +0.02 (c 21.7, CHCl3); Rf 0.70 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3012, 2917, 2849, 1733; 1H NMR (400 
MHz, CDCl3) δH 5.45−5.23 (7H, m, 6 × =CH and CHOCO), 4.29 (2H, dd, 
J = 12.0 and 4.0 Hz, 2 × CH2OCO), 4.14 (2H, dd, J = 12.0 and 6.0 Hz, 2 
× CH2’OCO), 2.87−2.74 (4H, m, 2 × =CCH2C=), 2.35−2.26 (6H, m, 3 
× CH2COO), 2.14−2.01 (4H, m, =CCH2CH3 and = CCH2CH2), 
1.67−1.56 (6H, m, 3 × CH2CH2COO), 1.38−1.18 (64H, m, 32 × CH2), 
0.98 (3H, t, J =7.5 Hz, =CCH2CH3), 0.88 (6H, t, J =7.0 Hz, 2 × CH3);  
13C NMR (101 MHz, CDCl3) δC 173.5, 173.4, 173.0, 132.1, 130.4, 128.5, 
128.4, 127.9, 127.3, 69.0, 62.3 (2), 34.4, 34.3, 34.2, 32.1, 30.1(2), 
30.0(2), 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 27.4, 
25.8, 25.7, 25.1, 25.0, 24.9, 22.8, 20.7, 14.4, 14.3; HRMS (ESI+) calc. for 
C57H104O6Na [M + Na]+ 907.7725, found 907.7717. 
2.1.2.17. 2,3-Dioctadecanoyl-1-(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl)- 
sn-glycerol, (S)-4b. (S)-4b was prepared using General Procedure C, and 
the spectroscopic data was identical to that obtained for (R)-4b. For 
further details, please see Supplementary material. 
2.1.2.18. 3-(5Z,8Z,11Z,14Z,17Z)-Eicosa-5,8,11,14,17-pentaenoyl)-1,2- 
dihexadecanoyl-sn-glycerol, (R)-5a. (R)-5a was prepared using General 
Procedure C, with (S)-3a (100 mg, 0.17 mmol), EPA (64.0 μL, 0.19 
mmol, 1.1 equiv.), EDCI (39.0 mg, 0.20 mmol, 1.2 equiv.) and DMAP 
(8.0 mg, 0.07 mmol, 0.4 equiv.) in CH2Cl2 (0.4 mL). Purification via 
column chromatography (petroleum ether / EtOAc (5 %) gave (R)-4a 
(145 mg, 0.17 mmol, 99 %) as a white waxy solid (with a tint of 
yellow); 
[α]D25 +0.17 (c 15.1, CHCl3); Rf 0.80 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3014, 2917, 2849, 1735; 1H NMR (400 
MHz, CDCl3) δH 5.46−5.22 (11H, m, 10 × =CH and CHOCO), 4.29 
(2H, dd, J = 12.0 and 4.0 Hz, 2 × CH2OCO), 4.18−4.11 (2H, m, 2 × 
CH2’OCO), 2.90−2.75 (8H, m, 4 × =CCH2C=), 2.37−2.26 (6H, m, 3 
× CH2COO), 2.16−2.03 (4H, m, =CCH2CH3 and = CCH2CH2), 1.70 
(2H, quin, J =7.5 Hz, =CCH2CH2CH2COO), 1.65−1.55 (4H, m, 2 × 
CH2CH2COO), 1.36−1.18 (48H, m, 24 × CH2), 0.98 (3H, t, J =7.5 Hz, 
=CCH2CH3), 0.88 (6H, t, J =7.0 Hz, 2 × CH3); 13C NMR (101 MHz, 
CDCl3) δC 173.3, 173.0, 172.9, 132.0, 129.0, 128.8, 128.6, 128.3, 
128.2, 128.1, 128.0, 127.9, 127.0, 68.9, 62.2, 62.1, 34.2, 34.1, 33.4, 
31.9, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 28.9, 26.5, 25.6, 
25.5, 24.9, 24.8, 24.7, 22.7, 20.6, 14.3, 14.1; HRMS (ESI+) calc. for 
C55H96O6Na [M + Na]+ 875.7099, found 875.7101. 
2.1.2.19. 1-(5Z,8Z,11Z,14Z,17Z)-Eicosa-5,8,11,14,17-pentaenoyl)-2,3- 
dihexadecanoyl-sn-glycerol, (S)-5a. (S)-5a was prepared using General 
Procedure C, and the spectroscopic data was identical to that obtained 
for (R)-5a. For further details, please see Supplementary material. 
2.1.2.20. 3-(5Z,8Z,11Z,14Z,17Z)-Eicosa-5,8,11,14,17-pentaenoyl)-1,2- 
dioctadecanoyl-sn-glycerol, (R)-5b. (R)-5b was prepared using General 
Procedure C, with (S)-3b (301 mg, 0.48 mmol), EPA (170 μL, 0.53 
mmol, 1.1 equiv.), EDCI (111 mg, 0.58 mmol, 1.2 equiv.) and DMAP 
(14.0 mg, 0.12 mmol, 0.2 equiv.) in CH2Cl2 (1.2 mL). Purification via 
column chromatography (petroleum ether / EtOAc (5 %) gave (R)-5b 
(413 mg, 0.45 mmol, 94 %) as a white waxy solid (with a tint of 
yellow); 
[α]D25 +0.18 (c 12.3, CHCl3); Rf 0.70 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3013, 2917, 2849, 1735; 1H NMR (400 
MHz, CDCl3) δH 5.45−5.23 (11H, m, 10 × =CH and CHOCO), 
4.36−4.22 (2H, m, 2 × CH2OCO), 4.18−4.11 (2H, m, 2 × CH2’OCO), 
2.90−2.75 (8H, m, 4 × =CCH2C=), 2.40−2.25 (6H, m, 3 × 
CH2COO), 2.17−2.02 (4H, m, =CCH2CH3 and = CCH2CH2), 1.70 (2H, 
quin, J =7.5 Hz, =CCH2CH2CH2COO), 1.65−1.56 (4H, m, 2 × 
CH2CH2COO), 1.38−1.18 (56H, m, 28 × CH2), 0.97 (3H, t, J =7.5 Hz, 
=CCH2CH3), 0.88 (6H, t, J =7.0 Hz, 2 × CH3); 13C NMR (101 MHz, 
CDCl3) δC 173.4, 173.2, 173.0, 132.2, 129.1, 128.9, 128.7, 128.4, 
128.3, 128.2, 128.0, 127.2, 69.0, 62.4, 62.3, 34.4, 34.2, 33.6, 32.1, 
29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 29.2, 29.1, 29.0, 26.7, 25.8, 
25.7, 25.1, 25.0, 24.9, 22.9, 20.7, 14.4, 14.3; HRMS (ESI+) calc. for 
C59H104O6Na [M + Na]+ 931.7725, found 931.7701. 
2.1.2.21. 1-(5Z,8Z,11Z,14Z,17Z)-Eicosa-5,8,11,14,17-pentaenoyl)-1,2- 
dioctadecanoyl-sn-glycerol, (S)-5b. (S)-5b was prepared using General 
Procedure C, and the spectroscopic data was identical to that obtained 
for (R)-5b. For further details, please see Supplementary material. 
2.1.2.22. 3-(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19- 
hexaenoyl)-1,2-dihexadecan-oyl-sn-glycerol, (R)-6a. (R)-6a was 
prepared using General Procedure C, with (S)-3a (331 mg, 0.58 
mmol), DHA (213 μL, 0.61 mmol, 1.05 equiv.), EDCI (122 mg, 0.64 
mmol, 1.1 equiv.) and DMAP (14.0 mg, 0.12 mmol, 0.2 equiv.) in 
CH2Cl2 (1.5 mL). Purification via column chromatography (petroleum 
ether / EtOAc (5 %) gave (R)-6a (512 mg, 0.58 mmol, 99 %) as a white 
waxy solid (with a tint of yellow); 
[α]D25 +0.08 (c 13.5, CHCl3); Rf 0.70 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3014, 2917, 2849, 1734; 1H NMR (400 
MHz, CDCl3) δH 5.46−5.23 (12H, m, 12 × =CH and CHOCO), 4.29 
(2H, dd, J = 12.0 and 4.5 Hz, 2 × CH2OCO), 4.20−4.10 (2H, m, 2 × 
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CH2’OCO), 2.91−2.76 (10H, m, 5 × =CCH2C=), 2.43−2.35 (4H, m, 
=CCH2CH2COO), 2.31 (2H, t, J =7.5 Hz, CH2COO), 2.30 (2H, t, J 
=7.5 Hz, CH2COO), 2.08 (2H, quin, J =7.5 Hz, =CCH2CH3), 
1.67−1.55 (4H, m, 2 × CH2CH2COO), 1.36−1.18 (48H, m, 24 × 
CH2), 0.97 (3H, t, J =7.5 Hz, =CCH2CH3), 0.88 (6H, t, J =7.0 Hz, 2 × 
CH3); 13C NMR (101 MHz, CDCl3) δC 173.3, 172.9, 172.5, 132.0, 129.5, 
128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 128.0 127.9, 127.7, 127.0, 
68.6, 62.3, 62.1, 34.2, 34.1, 33.9, 31.9, 29.9, 29.8, 29.7, 29.6, 29.5, 
29.4, 29.3, 29.2, 29.1, 29.0, 25.6, 25.5, 25.4, 24.9, 24.8, 22.7, 22.6, 
20.6, 14.3, 14.1; HRMS (ESI+) calc. for C57H98O6Na [M + Na]+ 
901.7256, found 901.7256. 
2.1.2.23. 1-(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19- 
hexaenoyl)-2,3-dihexadecan-oyl-sn-glycerol, (S)-6a. (S)-6a was prepared 
using General Procedure C, and the spectroscopic data was identical to 
that obtained for (R)-6a. For further details, please see Supplementary 
material. 
2.1.2.24. 3-(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19- 
hexaenoyl)-1,2-dioctadecan-oyl-sn-glycerol, (R)-6b. (R)-6b was prepared 
using General Procedure C, with (S)-3b (100 mg, 0.16 mmol), DHA 
(67.0 μL, 0.19 mmol, 1.2 equiv.), EDCI (35.0 mg, 0.18 mmol, 1.1 
equiv.) and DMAP (5.0 mg, 0.04 mmol, 0.3 equiv.) in CH2Cl2 (0.4 mL). 
Purification via column chromatography (petroleum ether / EtOAc (5 
%) gave (R)-6b (139 mg, 0.15 mmol, 94 %) as a white waxy solid (with 
a tint of yellow); 
[α]D25 +0.10 (c 10.1, CHCl3); Rf 0.70 (petroleum ether / EtOAc (10 
%)); IR (thin film, νmax / cm−1) 3013, 2917, 2849, 1735; 1H NMR (400 
MHz, CDCl3) δH 5.45−5.23 (13H, m, 12 × =CH and CHOCO), 4.30 
(2H, dd, J = 12.0 and 4.0 Hz, 2 × CH2OCO), 4.21−4.10 (2H, m, 2 × 
CH2’OCO), 2.91−2.75 (10H, m, 5 × =CCH2C=), 2.41−2.36 (4H, m, 
=CCH2CH2COO), 2.31 (2H, t, J =7.5 Hz, CH2COO), 2.30 (2H, t, J 
=7.5 Hz, CH2COO), 2.12−2.03 (2H, m, =CCH2CH3), 1.66−1.56 (4H, 
m, 2 × CH2CH2COO), 1.38−1.18 (56H, m, 28 × CH2), 0.97 (3H, t, J 
=7.5 Hz, =CCH2CH3), 0.88 (6H, t, J =7.0 Hz, 2 × CH3); 13C NMR 
(101 MHz, CDCl3) δC 173.4, 173.0, 172.7, 132.2, 129.6, 128.6, 128.5, 
128.4, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.0, 69.0, 62.4, 
62.2, 34.4, 34.2, 34.1, 32.1(2), 29.9, 29.8(2), 29.7, 29.6, 29.5, 29.4, 
29.3, 29.2, 29.1, 29.0, 25.8, 25.7, 25.1, 25.0, 24.9, 22.9, 22.8, 20.7, 
14.4, 14.3; HRMS (ESI+) calc. for C61H106O6Na [M + Na]+ 957.7882, 
found 957.7880. 
2.1.2.25. 1-(4Z,7Z,10Z,13Z,16Z,19Z)-Docosa-4,7,10,13,16,19- 
hexaenoyl)-2,3-dioctadecan-oyl-sn-glycerol, (S)-6b. (S)-6b was prepared 
using General Procedure C, and the spectroscopic data was identical to 
that obtained for (R)-6b. For further details, please see Supplementary 
material. 
2.2. HPLC enantiomer resolution and enantiopurity analysis 
2.2.1. Materials and reagents 
The enantiostructured TAGs (sn-16:0-16:0-DHA, sn-DHA-16:0-16:0, 
sn-18:0-18:0-DHA, sn-DHA-18:0-18:0, sn-16:0-16:0-EPA, sn-EPA-16:0- 
16:0, sn-18:0-18:0-EPA, sn-EPA-18:0-18:0, sn-16:0-16:0-ALA, sn-ALA- 
16:0-16:0, sn-18:0-18:0-ALA and sn-ALA-18:0-18:0) were analyzed by 
using chiral-phase LC method to investigate their chromatographic 
elution behavior in the chiral environment and to confirm the en-
antiopurity. All samples were diluted to hexane or to a mixture of 
hexane and isopropanol (3:2, v/v). Both solvents were HPLC grade and 
purchased from VWR International (Radnor, PA). One enantiomer of 
each synthesized enantiopair was analyzed as such to get the retention 
times and to automate the switching between the columns. Enantiopairs 
were analyzed as a mixture of 75 %:25 % to determine their en-
antiomeric separation and the elution order and as an enantiomeric 
mixture of 99 %:1 % to study the enantiopurity. 
2.2.2. HPLC instrumentation 
To improve the chromatographic separation by increasing the 
column length, chiral recycling HPLC (R-HPLC) method described 
previously (Kalpio et al., 2015) was applied, using two polysaccharide- 
based chiral stationary phases, CHIRALCEL OD-RH (150 × 4.6 mm, 5 
μm, Chiral Technologies Europe, Illkirch, France), in polar-organic 
phase mode. A precolumn (10 × 4.0 mm, 5 μm) was connected outside 
to equalize the cycles. Methanol (Sigma-Aldrich Corporation, St. Louis, 
MO) was used as a mobile phase and isopropanol as the washing so-
lution. The column temperature was 25 °C, flow rate 0.5 mL/min, and 
injection volume 10 μL. Before injections, samples were diluted to 
isopropanol to a concentration of 1 mg/mL. The samples were detected 
using a UV detector at 205 nm. The sample recycling system with a ten- 
position valve allowed analytes to alternate between two similar chiral 
columns enabling enantioseparation. Once timed separately for each 
enantiopair by used input, the switching between two columns was 
automated. Before enantiomeric resolution, good chromatographic 
performance, including peak shape and width, was ensured. The flow 
rate of the mobile phase and sample size were optimized to narrow 
down the peak width. With the R-HPLC configuration containing two 
columns, the influence of flow rate on column pressure was followed 
carefully. 
2.2.3. Data treatment 
The peak areas were integrated using a LabSolutions 5.57 software 
(Shimadzu, Kyoto, Japan). The following data analysis parameters were 
used: width 200 s, slope 150–200 μV/min, drift 0 (automatic) and 
minimum area 1000 counts. Due to the different enantiomeric resolu-
tion, the value for slope had to be adjusted. However, the similar data 
analysis parameters for each enantiopair were applied, and conse-
quently, the results were comparable. Within each enantiopair, the 
peak area ratio was regarded as the ratio of concentrations between the 
two enantiomers separated. For calculations, the average value of 2–4 
last peak pairs was used depending on the efficiency of enantiomeric 
separation (Table 3). 
Enantiomeric resolution (Rs) was calculated by the instrument soft-
ware according to Eq. (1). 
=
+
Enantiomeric resolution R t t
W W




where tR1 = retention time, tR2 = retention time of previous peak, W 
= peak width, Wp = peak width of previous peak 
The peak width (W) is the time between two intersection points on 
the baseline by the tangent lines drawn from the left and right inflection 
of a peak. 
Enantiopurity. There are different calculation procedures for en-
antiopurity due to the different methods used for determination. IUPAC 
defines enantiopurity as enantiomer excess (Moss, 2009), and thus the 




×Enantiomer excess ee t t
t t
, (%) ( [ ] [ ]
[ ] [ ]
) 100ri rii
ri rii (2) 
where [tri] and [trii] are the relative ratios of areas of the major and 
minor enantiomers, respectively. The areas were automatically de-
termined by LabSolution software. The ee (%) was calculated by first 
summing the areas of both peaks and determining their relative ratios. 
Impurity assessment. In addition, the proportion of impurity can be 
calculated (Eq. 3). 
=
+
×Proportion of Impurity Area t
t t
( %) ( [ ]
[ ] [ ]
) 100rii
ri rii (3) 
, where [tri] and [trii] are as stated before. 
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3. Results and discussion 
3.1. Synthesis 
The synthetic route illustrated in Scheme 1 was followed for the 
synthesis of the structured TAGs (shown for the R-enantiomers) com-
mencing from (S)-solketal. This is a very similar approach to the one 
that was followed in our previously described synthesis of enantiopure 
AAB type TAGs possessing two identical saturated fatty acyl groups 
(palmitic or stearic acids) along with one unsaturated fatty acid, either 
as oleic acid or linoleic acid (Kristinsson et al., 2014). In that case no 
enzyme was involved and the EDCI coupling agent was used to in-
troduce the saturated fatty acyl groups chemically into the sn-3 and sn-2 
positions of the benzylated glycerol adduct (S)-1, whereas in the cur-
rent approach this was executed enzymatically by use of immobilized 
Candida antarctica lipase (CAL). In the final step, the pure n-3 PUFAs 
(ALA, EPA and DHA) were introduced to the sn-1 terminal position by 
Steglich esterification by use of the EDCI coupling agent after removal 
of the benzyl protective moiety by catalytic hydrogenolysis over Pd/C. 
Referring to Scheme 1 the benzyl-protected glycerol derivatives (R)- 
1 and the corresponding (S)-1 were accomplished by a previously de-
scribed two-step procedure (Kristinsson et al., 2014), starting from (S)- 
and (R)-solketals, respectively, and obtained in excellent yields (94 and 
95 % over the two steps, respectively). Palmitic acid or stearic acid was 
introduced to both hydroxyl groups of (R)-1 by use of CAL-B to ac-
complish benzyl protected (S)-2a (palmitic acid) and (S)-2b (stearic 
acid) in excellent yields, 97 and 92 %, respectively. In our previous 
report these derivatives were prepared by aid of EDCI coupling agent 
and were not purified prior to the debenzylation. The enzymatic reac-
tion was performed without solvent under vacuum at 80 °C. It took 24 h 
for the reaction to proceed to completion and in this reaction, we have 
firm reasons to believe that the fatty acids were incorporated into the 2- 
position by acyl-migration, promoted by the high temperature and the 
presence of protons from the fatty acids (Haraldsson et al., 1995). The 
diacylated adducts (S)-2a and (S)-2b were isolated and purified by 
crystallization from ethanol. Similarly, the corresponding antipodal 
adducts (R)-2a and (R)-2b were obtained in 95 and 80 % yields, re-
spectively. 
As before, deprotection of the benzyl moiety was executed by cat-
alytic hydrogenolysis over Pd/C by aid of catalytic amounts of per-
chloric acid (Hartung and Simonoff, 1953; Rylander, 1990). The de-
protection took place very cleanly with no sign of acyl-migration as was 
firmly established by 400 MHz 1H and 13C NMR spectroscopy analysis. 
That technique is of great use to monitor a full regiocontrol of reactions 
involving 1,3- and 1,2-DAGs as well as 1- and 2-MAGs as has been 
described in details in previous reports (Halldorsson et al., 2003;  
Magnusson and Haraldsson, 2012, 2010). There were no indications of 
any 1,3-DAGs present in the products from the hydrogenolysis reaction. 
The resulting enantiostructured DAGs (S)-3a and (S)-3b were accom-
plished in 98 and 80 % yields, respectively, after recrystallization from 
hexane. Similarly, the antipodal (R)-derivatives were obtained in 97 
and 87 % yields, respectively, for (R)-3a and (R)-3b. 
In the final step the DAGs (S)-3a,b and (R)-3a,b were acylated with 
ALA, EPA and DHA to achieve the corresponding (R)- and (S)-4a,b, (R)- 
and (S)-5a,b and (R)- and (S)-6a,b, respectively, using EDCI as a cou-
pling agent in presence of DMAP in dichloromethane at r.t. All products 
were obtained in excellent yields after purification by silica gel column 
chromatography, except (S)-5b that was accomplished in 82 % yield.  
Table 1 reveals the yields and specific optical rotation values for the 
enantiostructured TAG products (R)-4a,b - 6a,b and the (S)- 4a,b - 6a,b 
antipods. All these compounds were fully characterized by 400 MHz 1H 
and 13C NMR and IR spectroscopy analyses and their high-resolution 
Scheme 1. The synthetic route for the struc-
tured TAGs (shown for the R-enantiomers) 
commencing from (S)-solketal. Reagents and 
conditions: (a) NaH, THF, then BnBr; (b) 1 M 
HCl, H2O/EtOH, reflux30 min.; (c) Palmitic or 
stearic acid, CAL-B, vacuum, 80 °C; (d) H2, 10 
% Pd/C, cat. HClO4, THF/pet. ether, r.t.; (e) 
PUFA, EDCI, DMAP, CH2Cl2, r.t. 
Table 1 
The identities of the enantiostructured TAG products (S)-4a,b – 6a,b and (R)-4a,b – 6a,b, constituting pure ALA (4), EPA (5) and DHA (6) together with palmitic (a) 
and stearic (b) acids, along with their obtained yields and specific optical rotations.         
Product sn-1 sn-2 sn-3 Abbreviation Yield (%) [a]20D  
(S)-4a ALA C15H31COO- C15H31COO- sn-ALA-16:0-16:0 95  −0.02 
(S)-4b ALA C17H35COO- C17H35COO- sn-ALA-18:0-18:0 96  −0.04 
(R)-4a C15H31COO- C15H31COO- ALA sn-16:0-16:0-ALA 96  0.02 
(R)-4b C17H35COO- C17H35COO- ALA sn-18:0-18:0-ALA 96  0.02 
(S)-5a EPA C15H31COO- C15H31COO- sn-EPA-16:0-16:0 99  −0.17 
(S)-5b EPA C17H35COO- C17H35COO- sn-EPA-18:0-18:0 82  −0.18 
(R)-5a C15H31COO- C15H31COO- EPA sn-16:0-16:0-EPA 97  0.17 
(R)-5b C17H35COO- C17H35COO- EPA sn-18:0-18:0-EPA 94  0.18 
(S)-6a DHA C15H31COO- C15H31COO- sn-DHA-16:0-16:0 99  −0.17 
(S)-6b DHA C17H35COO- C17H35COO- sn-DHA-18:0-18:0 99  −0.09 
(R)-6a C15H31COO- C15H31COO- DHA sn-16:0-16:0-DHA 94  0.08 
(R)-6b C17H35COO- C17H35COO- DHA sn-18:0-18:0-DHA 93  0.10 
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mass spectrometry analyses (HRMS) offered satisfactory results. The 
specific optical rotation values warrant a comment in remaining ex-
tremely low. This was to be expected as a result of the cryptoactivity 
behavior that is characteristic of chiral TAGs that was also observed in 
our previous studies involving the AAB type TAGs. The cryptoactivity 
term refers to compounds displaying specific rotation remaining close 
to zero and hardly measureable (Foss et al., 2005; Schlenk, 1965). Baer 
and Fischer were the first to report such behavior for TAGs in the late 
1930s (Baer and Fischer, 1939; Fischer and Baer, 1941). As can be 
noticed from the results in Table 1 the specific optical rotation absolute 
values ranged between 0.02 to 0.18, lowest for the ALA adducts, 
however, the signs remained consistent in terms of negative values for 
all the (S)- and positive for the (R)-TAGs. 
By the methodology described we have also succeeded in synthe-
sizing tens of grams of enantiostructured TAGs possessing pure DHA 
along with stearic acid (25 g of each of the TAG enantiomers (R)- and 
(S)-6b) and palmitic acid (50 g each of the (R)- and (S)-6a en-
antiomers). The former TAGs with DHA and stearic acid have already 
been submitted to animal bioavailability studies on rats along with 25 g 
of the corresponding symmetrically ABA structured TAG possessing 
DHA in the 2-position and stearic acid in the remaining 1,3-positions 
accomplished by previously described procedures (Linderborg et al., 
2019). The corresponding TAGs possessing DHA and palmitic acid 
syntheses have also been completed (50 g of each TAG type) that will be 
used in further animal studies. For these large-scale syntheses DHA of 
purity levels ≥ 95 % was used, whereas in the material intended for the 
chiral separation studies the purity levels of all n-3 PUFAs including 
DHA were 99 %. 
3.2. Chromatographic results 
The adjusted retention times (t'R=tR – tM) after the first column and 
equivalent carbon numbers of the TAGs [ECN, defined as the number of 
carbon atoms in the fatty acid residues (ACN) minus twice the number 
of DBs] are presented at Table 2. 
Both the length of the acyl chain and the number of DBs of the fatty 
acids have a crucial impact on retention of TAGs. In our previous study, 
the retention of TAGs decreased with increasing unsaturation and with 
decreasing acyl chain length when polar mobile phase was used. In the 
current study, TAGs with C16–C20 fatty acids were eluted in the order 
of ECN, in agreement with our previous findings (Kalpio et al., 2015). 
Additionally, the current study showed that presence of an n-3 PUFA 
with 0–5 DBs in the TAG did not change elution order based on the 
ECN. However, when the number of DBs increased from 5 (EPA) to 6 
(DHA), the elution order of TAGs did not follow the ECN values. TAGs 
containing DHA with six DBs eluted later than TAGs containing EPA 
with five DBs, even though the ECN were the same. The main reason is 
likely the spatial configuration of very long carbon chains of the n-3 
PUFAs in the TAG molecules (Řezanka et al., 2018). Řezanka and 
coworkers also noticed certain abnormalities in the retention with even 
up to 20 min difference in the retention times of TAGs with the same 
ECN, when TAGs containing at least one very long chain fatty acid were 
chromatographed on two chiral (3,5-dimethylphenylcarbamate mod-
ified β-cyclodextrin) columns using gradient of hexane and hexane/2- 
propanol. Despite the different chromatographic conditions applied, 
similar mechanisms probably explain the elution behavior of DHA- 
TAGs: the interactions of the DHA enantiomers with the mobile phase 
and the stationary phase. Cis-unsaturated fatty acid tails of DHA-TAGs 
bent to a greater extent than the less unsaturated PUFAs, due to the 
higher number of cis-double bonds present, each causing a permanent 
kick and bending in the hydrocarbon chain. 
Based on the findings of previous research and the current study, 
ECN values should be used to predict the order of elution in chiral 
environment only for TAGs containing long chain PUFAs with 1–5 DBs 
under similar chromatographic conditions. Even though some sys-
tematic behavior can be noticed, it is a challenging task to find any 
common rule about the elution order of chiral TAGs. This is due to the 
fact that the chiral recognition mechanisms at molecular level are still 
not fully understood in the chromatography of lipids. In addition to the 
traditional comprehensive lipid profiling, one trend of lipidomic studies 
is to aim for a deeper understanding of a specific lipid class (Yang et al., 
2016). Thus, all new information on the chiral retention behavior at the 
molecular level is essential for further development in the field. 
3.3. Enantiomer resolution and elution order 
The applied R-HPLC method confirmed the presence of two en-
antiomers in each of the pairs synthesized. The method was demon-
strated to enable the resolution of TAG enantiomers with at least up to 
six DBs. Resolution of the chiral separation of enantiopairs examined 
after the last column calculated by the instrument software varied be-
tween 1.0 and 3.8 (Fig. 1). Only TAGs containing DHA were separated 
with one column without recycling, but not to the baseline. The peak 
shape and area remained constant and the peak broadening did not 
limit the analysis. Consequently, recycling was continued until the 
desired resolution was achieved. All enantiopairs were clearly sepa-
rated after four columns. Previously, less peak broadening and better 
separation was offered with two identical columns compared to single- 
column (Liu et al., 2014). 
The non-destructive UV–vis detection enabled elucidation of the 
whole separation. As TAG enantiomers have identical physicochemical 
properties in an isotropic environment (Sánchez et al., 2012), the de-
tector response is the same for both enantiomers. Usual disadvantages 
in lipid analysis, namely differences in sensitivity between saturated 
and unsaturated TAGs and insufficient sensitivity for all saturated TAGs 
(Holčapek et al., 2005), did not hinder the analysis in this study. 
Elution order for SSU/USS type enantiopairs with two saturated and 
one unsaturated fatty acids was in accordance with earlier findings 
(Kalpio et al., 2015). The enantiomer with an n-3 PUFA in the sn-1 
position eluted faster than the enantiomer with the unsaturated fatty 
acid in the sn-3 position. Despite the different retention behavior of 
DHA-TAGs compared to other TAGs, there was no difference in elution 
order between DHA-TAG enantiomers. The enantiomeric elution order 
has been opposite when non-polar solvents like hexane-based mobile 
phases were used (Lísa and Holčapek, 2013; Řezanka et al., 2018). 
3.4. Enantiopurity 
With all enantiomers examined the ee (%) was more than 96 % 
(Table 3). No impurities of the opposite enantiomer were detected from 
sn-ALA-16:0-16:0. The small shoulder of the opposite enantiomer i.e. 
the peak area of impurity was less than 2 % of the peak area of the 
actual target compound. Performance of the system to detect small 
enantiomeric impurities was confirmed using a sample of each en-
antiomer spiked with 1 % of the opposite enantiomer. When comparing 
Table 2 
Chromatographic results.     
Enantiomeric TAG pairs ECN (=ACN – 2 
× DB) 
Adjusted retention time, t’R (min), 
after the first column  
sn-EPA-16:0-16:0 42 19.10 
sn-16:0-16:0-EPA 42 19.96 
sn-ALA-16:0-16:0 44 21.01 
sn-16:0-16:0-ALA 44 21.64 
sn-DHA-16:0-16:0 42 21.30 
sn-16:0-16:0-DHA 42 22.70 
sn-EPA-18:0-18:0 46 29.48 
sn-18:0-18:0-EPA 46 30.29 
sn-ALA-18:0-18:0 48 31.49 
sn-18:0-18:0-ALA 48 32.81 
sn-DHA-18:0-18:0 46 33.36 
sn-18:0-18:0-DHA 46 35.62 
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a chromatogram of enantiostructured TAG with the one spiked with 1 
% of the less abundant enantiomer, the opposite enantiomer was clearly 
visible in the latter (Fig. 2). Fig. 2 illustrates the six column passes of 
three samples; enantiostructured sn-EPA-18:0-18:0, sn-EPA-18:0-18:0 
spiked with 1 % sn-18:0-18:0-EPA and sn-EPA-18:0-18:0 spiked with 25 
% sn-18:0-18:0-EPA. After six columns sn-18:0-18:0-EPA is clearly se-
parated from sn-EPA-18:0-18:0, and even 1 % impurity is clearly illu-
strated by comparing the blue chromatogram to black one. 
Despite the similar physical and chemical characteristics, en-
antiomers can and often do exhibit different properties (D’Orazio et al., 
Fig. 1. Chiral R-HPLC-UV chromatogram of six enantiopairs (mixtures of 75 % : 25 %), A) sn-DHA-16:0-16:0 co-injected with 25 % of sn-16:0-16:0-DHA enantiomer, 
B) sn-18:0-18:0-DHA co-injected with 25 % of sn-DHA-18:0-18:0 enantiomer, C) sn-EPA-16:0-16:0 co-injected with 25 % of sn-16:0-16:0-EPA enantiomer, D) sn-EPA- 
18:0-18:0 co-injected with 25 % of sn-18:0-18:0-EPA enantiomer, E) sn-ALA-16:0-16:0 co-injected with 25 % of sn-16:0-16:0-ALA enantiomer, F) sn-ALA-18:0-18:0 
co-injected with 25 % of sn-18:0-18:0-ALA enantiomer. Columns: CHIRALCEL OD-RH (150 × 4.6 mm, 5 μm), Mobile phase: methanol, Detector: UV SPD-20A at 205 
nm. 
Table 3 
Enantiopurity results.      
Enantiopairs ee (%) of the first eluting enantiomer 100 % ee (%) mixture 99 %:1 % Proportion of impurity (Area%) / Purity (Area%)  
sn-DHA-16:0-16:0 + sn-16:0-16:0-DHA 97.7 ± 0.6 (n = 3) 95.1 ± 0.4 (n = 3) 1.2 / 98.8 
sn-DHA-18:0-18:0 + sn-18:0-18:0-DHA 96.1 ± 0.5 (n = 3) 94.0 ± 0.1 (n = 3) 1.9 / 98.1 
sn-EPA-16:0-16:0 + sn-16:0-16:0-EPA 98.4 ± 0.3 (n = 2) 97.2 ± 0.5 (n = 2) 0.8 / 99.2 
sn-EPA-18:0-18:0 + sn-18:0-18:0-EPA 98.2 ± 0.2 (n = 2) 94.5 ± 0.2 (n = 2) 0.9 / 99.1 
sn-ALA-16:0-16:0 + sn-16:0-16:0-ALA >99 ± 0 (n = 4) 98.6 ± 0.9 (n = 4) n.da / 100 
sn-ALA-18:0-18:0 + sn-18:0-18:0-ALA 98.9 ± 0.2 (n = 3) 97.0 ± 0.5 (n = 4) trb / 100 
a n.d; not detected. 
b tr; trace.  
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2017). Thus, enantiopurity is essential in many applications. In phar-
maceutical applications, the methods that determine the specific optical 
rotation are commonly used for the characterization of the optical 
purity (Gergely, 2000). The chiroptical techniques like the measure-
ment of optical rotatory dispersion (ORD) and circular dichroism (CD) 
have also been applied to study saturated glycerides (Gronowitz and 
Herslof, 1975). Because the optical activity of TAGs is very low, the 
chiral chromatographic methods have a crucial role in studying en-
antiopurity. Recently, enantioselective chromatography has been in-
creasingly used not only as a tool for chiral analyses but also as a 
technique to determine enantiomeric impurities. The R-HPLC can be 
used to enhance separation efficiency and for example to be applied to 
study enantiopurity or other impurities in the sample (Liu et al., 2014;  
Trone et al., 2006). Enantioresolution is the main requirement of the 
reliable method to study enantiopurity due to the inability of UV de-
tector to detect the co-eluting impurities. 
4. Conclusions 
Twelve enantiostructured TAGs were successfully synthesized in a 
five-step chemoenzymatic approach by use of a lipase. Six pairs of TAG 
enantiomers were formed, all of the AAB type containing one n-3 PUFA 
(ALA, EPA or DHA) attached to the terminal sn-1 or sn-3 position of the 
glycerol backbone along with two palmitic or stearic acids located in 
the remaining positions. They were all obtained in high chemical purity 
within very high to excellent yields. These compounds are valuable 
material for bioavailability studies and as enantiopure reference com-
pounds for chromatographic separation and analysis. 
The chiral-phase recycling HPLC (R-HPLC) method enabled re-
solution of the synthesized TAG enantiomers, and their elution order 
and chromatographic behavior were firmly established. Elution order of 
the enantiomers was found to be in agreement with our previous 
findings determined in our previous study, with the enantiomer with an 
n-3 PUFA in the sn-1 position eluting faster than its enantiomer with the 
n-3 PUFA in the sn-3 position. However, the retention behavior of the 
TAG enantiomers containing very long chain fatty acid with six DBs 
(DHA) was different compared to the TAG enantiomers containing 
C12–C22 fatty acids with 0–5 DBs. Retention of DHA-TAGs was higher 
than TAGs containing ALA or EPA and they were enantioseparated 
without recycling. The elution order was based on the ECN for TAGs 
containing C16–C20 fatty acids with 0–5 DBs. However, DHA-con-
taining TAGs did not follow this elution order. All the DHA-TAGs eluted 
later than the EPA-TAGs with the same ECN values. Based on the re-
sults, we can conclude that no common rules can be applied to predict 
the elution behavior of all chiral TAGs, which highlights the importance 
of further studies in the field. 
The compounds analyzed with the chiral R-HPLC-UV were all of 
excellent enantiomeric excess (>96 %). Among the immense number of 
molecular species of natural TAGs, only a limited number of TAG re-
ference compounds, and practically no enantiopure TAGs, is commer-
cially available. Thus, reliable and workable synthesis is an obligatory 
route in order to study the bioactivities of TAG enantiomers and to 
study the chromatographic behavior of these compounds. 
Synthesis of enantiostructured TAGs together with the chiral R- 
HPLC method enables studies on the role of chirality in food and other 
biological systems. The knowledge whether a compound is naturally 
present as a pure enantiomer or with a specific enantiomeric ratio can 
lead to speculations on the importance of the enantiospecificity for a 
certain function. The stereospecific information on TAGs offers a new 
platform for investigations into lipid synthesis and metabolism. 
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